Clostridioides difficile infection recurrence in the VINCat hospitals: a prospective observational cohort study

dc.contributor.authorPujol Rojo, Miquel
dc.contributor.authorLimón, Enrique
dc.contributor.authorSopena, Nieves
dc.contributor.authorLópez-Contreras, Joaquín
dc.contributor.authorCastellà, Laia
dc.contributor.authorCuquet, Jordi
dc.contributor.authorLópez-Sánchez, Maria
dc.contributor.authorPérez, Rafel
dc.contributor.authorGudiol González, Carlota
dc.contributor.authorColoma, Ana
dc.contributor.authorMarimón, Mariló
dc.contributor.authorEspinach, Joan
dc.contributor.authorAndres, Marta
dc.contributor.authorMartos, Purificación
dc.contributor.authorHernández, Sergi
dc.contributor.authorAlmendral, Alexander
dc.contributor.authorSaliba, Patrick
dc.contributor.authorCarvalho Rodrigues, Gonçalo
dc.contributor.authorCalbo, Esther
dc.date.accessioned2022-11-22T15:54:26Z
dc.date.available2023-09-30T05:10:26Z
dc.date.issued2022-09-30
dc.date.updated2022-11-22T15:54:26Z
dc.description.abstractBackground: The 2016 cumulative incidence of Clostridioides difficile infection (CDI) in Spain was reported by the European Center for Disease Control to be above the mean of other European countries. The aim of this multicenter prospective observational cohort study was to examine the risk factors that determine 90-day CDI recurrence in Catalonia, Spain. Methods: The study included 558 consecutive adults admitted to hospital who had a symptomatic, first positive CDI diagnosis. Sociodemographic, clinical and epidemiological variables were recorded. The primary outcome was 90-day CDI recurrence. Results: In this Catalan population, having received more than one course of antibiotics in the 30 days prior to CDI diagnosis (odds ratio: 2.459; 95% CI: 1.195-5.060; p = 0.015) and active chemotherapy (odds ratio: 4.859; 95% CI: 1.495-15.792; p = 0.009) are significant predictors of 90-day CDI recurrence. Conclusion: The identification of independent risk factors of 90-day CDI recurrence will enable the optimization of preventive measures in at-risk populations.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec726868
dc.identifier.issn1746-0913
dc.identifier.urihttps://hdl.handle.net/2445/191069
dc.language.isocat
dc.publisherFuture Medicine
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.2217/fmb-2022-0076
dc.relation.ispartofFuture Microbiology, 2022, num. 17, p. 1445-1453
dc.relation.urihttps://doi.org/10.2217/fmb-2022-0076
dc.rights(c) Future Medicine, 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Infermeria de Salut Pública, Salut mental i Maternoinfantil)
dc.subject.classificationColitis
dc.subject.classificationAntibiòtics
dc.subject.classificationEfectes secundaris dels medicaments
dc.subject.classificationHigiene hospitalària
dc.subject.otherColitis
dc.subject.otherAntibiotics
dc.subject.otherDrug side effects
dc.subject.otherHospital hygiene
dc.titleClostridioides difficile infection recurrence in the VINCat hospitals: a prospective observational cohort study
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
726868.pdf
Mida:
330.99 KB
Format:
Adobe Portable Document Format